Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency

Post time 1 hour(s) ago

journal：Science Translational Medicine

Authors：Miranda C. Lahman; Thomas M. Schmitt; Kelly G. Paulson; Nathalie Vigneron; Denise Buenrostro; Felecia D. Wagener; Valentin Voillet; Lauren Martin; Raphael Gottardo; Jason Bielas; Julie M. McElrath; Derek L. Stirewalt; Era L. Pogosova-Agadjanyan; Cecilia C. Yeung; Robert H. Pierce; Daniel N. Egan; Merav Bar; Paul C. Hendrie; Sinéad Kinsella; Aesha Vakil; Jonah Butler; Mary Chaffee; Jonathan Linton; Megan S. McAfee; Daniel S. Hunter; Marie Bleakley; Anthony Rongvaux; Benoit J. Van den Eynde; Aude G. Chapuis; Philip D. Greenberg

Published date：2022-2-9

DOI：10.1126/scitranslmed.abg8070

PDF link：https://www.science.org/doi/pdf/10.1126/scitranslmed.abg8070

Article link：https://doi.org/10.1126/scitranslmed.abg8070

Article Source：American Association for the Advancement of Science (AAAS)。

Remark：

Post time 1 hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[AAAS] Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AAAS] Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AAAS] Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency